T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease
- 17 November 2004
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 374 (2) , 132-135
- https://doi.org/10.1016/j.neulet.2004.10.042
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Internal Carotid Artery Occlusive Disease and Polymorphisms of Fractalkine Receptor CX3CR1Stroke, 2004
- Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout MiceCirculation, 2003
- Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial diseaseAtherosclerosis, 2003
- Decreased atherosclerosis in CX3CR1–/– mice reveals a role for fractalkine in atherogenesisJournal of Clinical Investigation, 2003
- Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and AtherosclerosisCirculation Research, 2001
- Polymorphism in the Promoter of Lipopolysaccharide Receptor CD14 and Ischemic Cerebrovascular DiseaseStroke, 2000
- Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic FlowThe Journal of Experimental Medicine, 1998
- Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and AdhesionPublished by Elsevier ,1997
- A new class of membrane-bound chemokine with a CX3C motifNature, 1997
- The effect of atherosclerosis on endothelium-dependent relaxation in the aorta and intracranial arteries of rabbitsJournal of Neurosurgery, 1989